Maschinenfabrik Berthold Hermle (MBH3) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
6 Oct, 2026Executive summary
2024 results weakened as cautious demand intensified in H2; international markets, automation solutions and service revenue helped cushion the downturn.
Strong finances supported continued investment despite lower orders, revenue and earnings; the 2025 outlook calls for a significant contraction.
Financial highlights
2024 revenue fell 8.3% to €487.9m from €532.3m; overseas revenue declined 6.2% to €308.5m and domestic revenue fell 11.8% to €179.4m.
EBIT decreased to €85.3m from €115.8m; profit before tax was €89.0m versus €118.4m, and net income was €65.9m versus €87.6m.
Orders received declined 7.8% to €456.2m; year-end backlog was €98.7m versus €130.5m.
Outlook and guidance
2025 revenue is expected to decline from just under 10% to ~25%, with earnings down disproportionately by 40% to 90%.
Medium-term demand is expected to remain sustained for high-performance machine tools and automated systems; the portfolio transition to GEN2 is underway.
Flexible working-time accounts are being reduced and short-time work implemented in H1 2025 amid weak conditions.
Latest events from Maschinenfabrik Berthold Hermle
- Weak demand cut H1 EBIT 22.1%; FY revenue outlook spans a high-single-digit to ~20% decline.MBH3
H1 2024 - Turnover proved resilient, but falling orders and utilisation cloud the FY outlook.MBH3
Q3 2024 - Q1 revenue fell 8.8% amid domestic weakness; FY guidance remains unchanged.MBH3
Q1 2025 - H1 earnings contracted sharply; FY turnover and EBIT are forecast to fall up to 15% and 80%.MBH3
H1 2025 - International orders lifted guidance despite weak domestic sales and lower operating results.MBH3
Q3 2025 - International demand lifted 2025 results, but 2026 earnings remain highly uncertain.MBH3
H2 2025 - Orders and revenue grew in Q1 as operating result improved and investments advanced.MBH3
Q1 2026 - Orders surged 16.1%; FY outlook targets ~10% revenue growth despite rising risks.MBH3
H1 2026